Login / Signup

Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.

Athanasios ArmakolasNektarios AlevizopoulosMartha StathakiConstantina PetrakiGeorge AgrogiannisMartina SamiotakiGeorge PanayotouEirini ChatzinikitaMichael Koutsilieris
Published in: British journal of cancer (2024)
These data indicate that the therapeutic targeting of PEc with the anti-PEc MAb may have considerable clinical benefit for prostate cancer patients.
Keyphrases
  • monoclonal antibody
  • prostate cancer
  • radical prostatectomy
  • electronic health record
  • big data
  • cancer therapy
  • machine learning